Maoka, Japan

Keiko Ishida

This inventor holds 1 USPTO granted patent. Top assignee: Kao Corporation. Active years: 2021.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Keiko Ishida. Retrieved from https://idiyas.com/inventor/keiko-ishida-shkilk5h

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2021

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Keiko Ishida: Innovator in Brain Function Enhancement

Introduction

Keiko Ishida is a prominent inventor based in Maoka, Japan. She has made significant contributions to the field of neuroscience through her innovative research and patents. Her work focuses on enhancing brain function and preventing brain dysfunction.

Latest Patents

Keiko Ishida holds a patent for an "Agent for activating astrocyte glucose metabolism." This invention provides a material effective for improving the activity of nerves in the brain or for preventing or ameliorating brain dysfunction. The agent comprises one or more active ingredients selected from hydrophobic solvent extracts of tien-cha, rooibos, grape, and black tea. This patent highlights her commitment to advancing brain health.

Career Highlights

Keiko Ishida is associated with Kao Corporation, where she applies her expertise in developing innovative solutions for brain function enhancement. Her work has garnered attention for its potential impact on improving cognitive health and addressing neurological issues.

Collaborations

Keiko collaborates with notable colleagues, including Koichi Misawa and Kohjiro Hashizume. Their combined efforts contribute to the advancement of research in the field of neuroscience.

Conclusion

Keiko Ishida's contributions to brain function enhancement through her innovative patents reflect her dedication to improving cognitive health. Her work continues to inspire advancements in neuroscience and offers hope for addressing brain dysfunction.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…